These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25903151)

  • 1. Potential natural products for Alzheimer's disease: targeted search using the internal ribosome entry site of tau and amyloid-β precursor protein.
    Tasi YC; Chin TY; Chen YJ; Huang CC; Lee SL; Wu TY
    Int J Mol Sci; 2015 Apr; 16(4):8789-810. PubMed ID: 25903151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease.
    Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):554-64. PubMed ID: 23276558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual action of memantine in Alzheimer disease: a hypothesis.
    Wu TY; Chen CP
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):273-7. PubMed ID: 19797019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice.
    Sun J; Zhang X; Wang C; Teng Z; Li Y
    Am J Chin Med; 2017; 45(8):1667-1682. PubMed ID: 29132216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes.
    Khalaf SS; Hafez MM; Mehanna ET; Mesbah NM; Abo-Elmatty DM
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):685-695. PubMed ID: 30759264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism.
    Li M; Pehar M; Liu Y; Bhattacharyya A; Zhang SC; O'Riordan KJ; Burger C; D'Adamio L; Puglielli L
    Neurobiol Aging; 2015 Oct; 36(10):2725-36. PubMed ID: 26174856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
    Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
    Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tetramethylpyrazine Analogue T-006 Alleviates Cognitive Deficits by Inhibition of Tau Expression and Phosphorylation in Transgenic Mice Modeling Alzheimer's Disease.
    Zhang G; Wu J; Huang C; Cheng J; Su Z; Zhu Z; Yang X; Guo B; Wu L; Zhang Z; Zhang G; Chen H; Sun Y; Wang Y
    J Mol Neurosci; 2021 Jul; 71(7):1456-1466. PubMed ID: 33403592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.
    Yu JZ; Li YH; Liu CY; Wang Q; Gu QF; Wang HQ; Zhang GX; Xiao BG; Ma CG
    CNS Neurol Disord Drug Targets; 2017; 16(2):199-209. PubMed ID: 27401064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.
    Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC
    Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cells.
    Ray B; Banerjee PK; Greig NH; Lahiri DK
    Neurosci Lett; 2010 Feb; 470(1):1-5. PubMed ID: 19948208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.
    Jiang XW; Liu WW; Wu YT; Wu Q; Lu HY; Xu ZH; Gao HY; Zhao QC
    J Ethnopharmacol; 2020 Mar; 249():112433. PubMed ID: 31783135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology.
    Baglietto-Vargas D; Medeiros R; Martinez-Coria H; LaFerla FM; Green KN
    Biol Psychiatry; 2013 Sep; 74(5):357-66. PubMed ID: 23312564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
    Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
    Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.